Products

TAXUS® Liberté® Long
Paclitaxel-Eluting Coronary Stent System

Advancing Safety in Long Lesions

The TAXUS Liberté Long Stent is designed for drug delivery while advancing safety and cath lab efficiency.

2-Year Safety

12mo MI

Long Lesion Trial Program

* Using the same inclusion criteria (lesions ≥26mm and ≤34mm), a significantly higher percentage of patients in the TAXUS Express Stent control arm required multiple stents to cover the lesion.

In the TAXUS ATLAS Long Lesion Trial, the primary endpoint was met, with a statistically significantly lower 9-month analysis segment Percent Diameter Stenosis for the TAXUS Liberté Long Stent versus the TAXUS Express Stent control (31.65% ± 17.24% versus 32.57% ± 19.28%, p=0.0010).